Behavioral therapy to reduce nightmares in REM sleep behavior disorder
Official title: Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
Run by University of Utah · NCT06441864 · Data updated 2026-11-12
This trial will test whether a non-medication behavioral therapy delivered by videoconference can reduce frequent nightmares in adults with REM sleep behavior disorder while involving a family member.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | July 15, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT06441864 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults in the United States with isolated or secondary RBD who have nightmares at least three times per week, live with a willing family member, and have stable sleep- or neurologic-related medications.
✕Probably not a fit
Patients with possible dementia, narcolepsy, posttraumatic stress disorder, those currently in trauma- or sleep-focused psychotherapy, or those who have already received behavioral treatment for nightmares may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with isolated or neurodegenerative-related REM Sleep Behavior Disorder and a cohabiting family member are enrolled and receive cognitive behavioral therapy for nightmares, including imagery rehearsal techniques, delivered via videoconference. Participants with RBD attend seven therapy sessions and their family members join two of those sessions; all participants complete two study assessments. Medications must be stable for at least one month prior to enrollment, and exclusion criteria include possible dementia, narcolepsy, PTSD, and prior behavioral nightmare treatment. The intervention aims to provide a nonpharmacologic option to reduce nightmare frequency and distress in this population.
Why it matters
Potential benefit: If successful, this could provide a non-drug way to reduce nightmare frequency and distress, improve sleep safety, and lessen partner sleep disruption.
How similar studies have gone: Imagery rehearsal therapy and cognitive behavioral approaches have shown benefit for idiopathic nightmares and PTSD-related nightmares, but they have been less studied specifically in REM Sleep Behavior Disorder.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease * Age 18 or older * Speak, read, and write English * Live in the United States * Nightmare frequency ≥3 times per week * Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder * Sleep, neurological, and psychiatric medications stable for at least 1 month and willing to keep medications stable through the course of the study * Live with a family member who is willing to participate in the study Exclusion Criteria: * Possible dementia * Narcolepsy * Posttraumatic stress disorder * Previous behavioral treatment for nightmares * Currently engaged in sleep- or trauma-focused psychotherapy * Taking a medication that could cause RBD, if the medication was started prior to onset of RBD symptoms Inclusion Criteria (Family Members): * Live with a family member who meets all of the above criteria * Age 18 or older * Speak, read, and write English * Live in the United States
Where it's running
-
University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Jennifer Mundt, PhD
- Email: RBDstudy@utah.edu
- Phone: 801-646-8287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if a non-drug therapy reduces nightmares in adults with narcolepsy
This study tests a talking-based therapy called imagery rehearsal therapy to see if it reduces frequent nightmares in adults with narcolepsy, with participants and sometimes their sleep partners involved in assessments.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Early PD signals in people with REM sleep behavior disorder
This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Multimodal prospective cohort of Parkinsonism
This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.
-
Unmet needs of people with isolated REM sleep behavior disorder and their partners
This project asks people with isolated REM sleep behavior disorder (iRBD) and their significant others about their informational, emotional, and practical needs using online questionnaires.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.